Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin-induced anticancer activities: recent insights
Stephen Safe, Vijayalekshmi Nair, Keshav Karki
Biological Chemistry (2017) Vol. 399, Iss. 4, pp. 321-335
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Obesity and cancer risk: Emerging biological mechanisms and perspectives
Konstantinos Avgerinos, Nikolaos Spyrou, Christos S. Mantzoros, et al.
Metabolism (2018) Vol. 92, pp. 121-135
Open Access | Times Cited: 1260
Metformin as an Anticancer Agent
Aleš Vančura, Pengli Bu, Madhura Bhagwat, et al.
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 10, pp. 867-878
Open Access | Times Cited: 235
Metformin: Is it a drug for all reasons and diseases?
Chris R. Triggle, Ibrahim Mohammed, Khalifa Bshesh, et al.
Metabolism (2022) Vol. 133, pp. 155223-155223
Open Access | Times Cited: 186
Preserving Insulin Secretion in Diabetes by Inhibiting VDAC1 Overexpression and Surface Translocation in β Cells
Enming Zhang, Israa Mohammed Al-Amily, Sarheed Mohammed, et al.
Cell Metabolism (2018) Vol. 29, Iss. 1, pp. 64-77.e6
Open Access | Times Cited: 137
Metformin as a geroprotector: experimental and clinical evidence
Veronika Piskovatska, Nadya Stefanyshyn, Kenneth B. Storey, et al.
Biogerontology (2018) Vol. 20, Iss. 1, pp. 33-48
Closed Access | Times Cited: 105
Anticancer mechanisms of metformin: A review of the current evidence
Bin Zhao, Jie Luo, Tongyao Yu, et al.
Life Sciences (2020) Vol. 254, pp. 117717-117717
Closed Access | Times Cited: 100
Phenformin as an Anticancer Agent: Challenges and Prospects
Ma Eugenia García Rubiño, Esmeralda Carrillo, Gloria Ruiz Alcalá, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3316-3316
Open Access | Times Cited: 97
Research on the Mechanisms of Plant Enrichment and Detoxification of Cadmium
Gui-Li Yang, Meng-Meng Zheng, Ai-Juan Tan, et al.
Biology (2021) Vol. 10, Iss. 6, pp. 544-544
Open Access | Times Cited: 76
A preclinical overview of metformin for the treatment of type 2 diabetes
Tingting Zhou, Xin Xu, Mengfan Du, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 106, pp. 1227-1235
Closed Access | Times Cited: 82
Pleiotropic Effects of Metformin on Cancer
Hans-Juergen Schulten
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 2850-2850
Open Access | Times Cited: 76
Metformin and Breast Cancer: Molecular Targets
João Faria, G. Negalha, Ana Azevedo, et al.
Journal of Mammary Gland Biology and Neoplasia (2019) Vol. 24, Iss. 2, pp. 111-123
Closed Access | Times Cited: 69
The Use of Metformin to Increase the Human Healthspan
Veronika Piskovatska, Kenneth B. Storey, Alexander Vaiserman, et al.
Advances in experimental medicine and biology (2020), pp. 319-332
Closed Access | Times Cited: 52
Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
Yi Zhang, Fang Zhou, Jiaheng Guan, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 250-250
Open Access | Times Cited: 19
High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells
Sharon Varghese, Samson Mathews Samuel, Elizabeth Varghese, et al.
Biomolecules (2019) Vol. 9, Iss. 1, pp. 16-16
Open Access | Times Cited: 53
Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead
Rashmi R. Shah, Peter Stonier
Journal of Clinical Pharmacy and Therapeutics (2018) Vol. 44, Iss. 1, pp. 6-22
Open Access | Times Cited: 52
Rescue of Retinal Degeneration in rd1 Mice by Intravitreally Injected Metformin
A Luodan, Ting Zou, Juncai He, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 47
Metformin Induces Apoptosis in Human Pancreatic Cancer (PC) Cells Accompanied by Changes in the Levels of Histone Acetyltransferases (Particularly, p300/CBP-Associated Factor (PCAF) Protein Levels)
Izabela Szymczak-Pajor, Józef Drzewoski, Ewa Świderska, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 115-115
Open Access | Times Cited: 16
Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review
Fereshtehsadat Jalali, Fatemeh Fakhari, Afrah Sepehr, et al.
Translational Oncology (2024) Vol. 45, pp. 101946-101946
Open Access | Times Cited: 6
Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet
Wei Zhu, Panpan Feng, Kunlun He, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 505, Iss. 2, pp. 523-529
Closed Access | Times Cited: 46
Metformin Suppresses Hypopharyngeal Cancer Growth by Epigenetically Silencing Long Non-coding RNA SNHG7 in FaDu Cells
Ping Wu, Yaoyun Tang, Xing Fang, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 39
Metal Complex Formation and Anticancer Activity of Cu(I) and Cu(II) Complexes with Metformin
Sherin Abdelrahman, Mawadda Alghrably, Marcello Campagna, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4730-4730
Open Access | Times Cited: 25
Inhibiting ROS-TFE3-dependent autophagy enhances the therapeutic response to metformin in breast cancer
Miduo Tan, Anshang Wu, Ni Liao, et al.
Free Radical Research (2018) Vol. 52, Iss. 8, pp. 872-886
Closed Access | Times Cited: 28
Metformin: A Promising Antidiabetic Medication for Cancer Treatment
Wei Mu, Yunyun Jiang, Guoqiang Liang, et al.
Current Drug Targets (2022) Vol. 24, Iss. 1, pp. 41-54
Closed Access | Times Cited: 13
Metformin Induces a Caspase 3-Unrelated Apoptosis in Human Colorectal Cancer Cell Lines HCT116 and SW620
Bustanur Rosidi, Diana Priyatno, T.P. Putra, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 475-485
Open Access | Times Cited: 8
Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells
Ying Wang, Yafei Zhang, Xiaomei Feng, et al.
Oncology Reports (2020) Vol. 45, Iss. 3, pp. 1249-1260
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top